Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Geneyx Analysis offers an all-encompassing solution for managing next-generation sequencing (NGS) data, efficiently transforming FASTQ files into clinical reports tailored for both hospital and commercial laboratories. This cutting-edge platform incorporates machine learning and artificial intelligence capabilities to uncover new biomedical insights, enhancing diagnostic efficiency and reducing turnaround times. By delivering a fully transparent and user-friendly interface, Geneyx Analysis empowers clinicians and researchers with complete control over data interpretation and simplifies the challenges associated with managing in-house bioinformatics workflows. Users can customize protocols to suit various gene panels, exomes, and genomes, while our extensive annotation engine facilitates the analysis of all genetic variants, including structural and copy number variations, as well as regulatory elements. In combination, Geneyx Analysis streamlines the diagnostic journey from sequencer output to finalized report, while also serving as a valuable resource for the discovery of novel variants. This platform not only enhances clinical capabilities but also paves the way for groundbreaking research in genomics.
Description
The Illumina DRAGEN Secondary Analysis system offers precise, thorough, and highly efficient processing of next-generation sequencing data. Utilizing a graph reference genome alongside machine learning techniques, it achieves remarkable accuracy. The workflow is exceptionally streamlined, capable of completely analyzing a 34x whole human genome in approximately 30 minutes when using the DRAGEN server v4. Additionally, it enhances this workflow by compressing FASTQ file sizes by up to five times. This system is adept at analyzing a variety of NGS data types, including whole genomes, exomes, methylomes, and transcriptomes. It is designed to be compatible with the user's preferred platform and is scalable to meet varying requirements. DRAGEN analysis consistently ranks as a leader in accuracy for both germline and somatic variant detection, as evidenced by its performance in industry competitions conducted by precisionFDA. This advanced analysis solution empowers laboratories of all sizes and specialties to maximize the potential of their genomic datasets. Moreover, the implementation of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to deliver hardware-accelerated genomic analysis algorithms, further enhancing its performance. Such advancements position DRAGEN as a vital tool in the ever-evolving field of genomics.
API Access
Has API
No
API Access
Has API
Yes
Integrations
Amazon Web Services (AWS)
No
BaseSpace Sequence Hub
No
Correlation Engine
No
Emedgene
No
Illumina Connected Analytics
No
Integrations
Amazon Web Services (AWS)
Yes
BaseSpace Sequence Hub
Yes
Correlation Engine
Yes
Emedgene
Yes
Illumina Connected Analytics
Yes
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
Yes
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Geneyx
Founded
2018
Country
Netherlands
Website
geneyx.com/geneyxanalysis/
Vendor Details
Company Name
Illumina
Country
United States
Website
www.illumina.com/products/by-type/informatics-products/dragen-secondary-analysis.html